Terazosin for system suitability
SIAL/Y0000666 - CRS, European Pharmacopoeia (EP) Reference Standard
Synonym: Terazosin hydrochloride dihydrate; 1-
CAS Number: 70024-40-7
Empirical Formula (Hill Notation): C19H25N5O4 · HCl · 2H2O
Molecular Weight: 459.92
MDL Number: MFCD00941408
Linear Formula: C19H25N5O4 · HCl · 2H2O
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C19H25N5O4.ClH.2H2O/c1 |
InChI key | NZMOFYDMGFQZLS-UHFFFAOYSA |
manufacturer/tradename | EDQM |
SMILES string | O.O.Cl.COc1cc2nc(nc(N)c2c |
Application: | It may be used as drug standard stock solution for determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques. |
Caution: | Please find SDS provided by EDQM here. ![]() ![]() |
General description: | Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
Packaging: | Unit quantity: 0.59 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue ![]() ![]() |
Symbol | ![]() |
Signal word | Warning |
Hazard statements | H302 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |